3 Reasons Growth Investors Will Love Boston Scientific (BSX)

Core Viewpoint - Investors are seeking growth stocks that can deliver above-average growth and exceptional returns, but identifying such stocks is challenging due to inherent risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Boston Scientific (BSX) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being highly desirable as it indicates strong future prospects [3] - Boston Scientific has a historical EPS growth rate of 21.3%, with projected EPS growth of 18.6% this year, significantly surpassing the industry average of 10.2% [4] Group 3: Cash Flow Growth - Higher-than-average cash flow growth is essential for growth-oriented companies, allowing them to expand without relying on external funding [5] - Boston Scientific's year-over-year cash flow growth is 26.5%, well above the industry average of 1.2% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 9.9%, compared to the industry average of 8% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with near-term stock price movements [7] - Boston Scientific has seen upward revisions in current-year earnings estimates, with the Zacks Consensus Estimate increasing by 2.1% over the past month [8] Group 5: Overall Assessment - Boston Scientific holds a Zacks Rank of 2 and a Growth Score of B, indicating its potential as an outperformer and a solid choice for growth investors [10]